Encompass Health (NYSE:EHC) Issues FY 2025 Earnings Guidance

Encompass Health (NYSE:EHC) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 4.670-4.960 for the period, compared to the consensus earnings per share estimate of 4.770. The company issued revenue guidance of $5.8 billion-$5.9 billion, compared to the consensus revenue estimate of $5.8 billion.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on EHC shares. Royal Bank of Canada increased their price target on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp raised their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Finally, Barclays boosted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Stock Performance

NYSE:EHC traded down $3.79 during mid-day trading on Thursday, reaching $98.41. 1,096,305 shares of the stock were exchanged, compared to its average volume of 643,975. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health has a 1 year low of $71.99 and a 1 year high of $104.55. The company has a 50 day simple moving average of $96.43 and a 200-day simple moving average of $95.08. The stock has a market capitalization of $9.91 billion, a P/E ratio of 23.77, a P/E/G ratio of 1.18 and a beta of 0.90.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Analysts anticipate that Encompass Health will post 4.29 earnings per share for the current fiscal year.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.